We're investing almost £1 million in pioneering research projects
Date
News
Date
Solengepras works in a different way to traditional Parkinson's medications and improved symptoms in this major study.
Date
Latest results show an improvement in movement symptoms after just 12 weeks of taking SNT-4728
Date
A new study aims to uncover whether a subset of people with Parkinson's may benefit from diabetes medications.
Date
Tavapadon, a dopamine agonist which can ease symptoms of Parkinson's, has been approved for use by the FDA.
Date
A study has shown that the therapy is safe, usable and may improve daytime sleepiness in Parkinson's.
Date
Results from a clinical trial of CUE1+, a chest-mounted device, has shown it's well tolerated by people with Parkinson's and has the potential to help manage movement symptoms.
Date
A Parkinson's UK funded study in Cambridge has shown that brain cells called astrocytes could be a potential target for future treatments.
Date
The STEM-PD trial team have shared that 6 out of 7 people who received the stem cell therapy have been able to reduce their Parkinson's medication.
Date
Initial results suggest the drug SNT-4728 was able to reduce inflammation in an area of the brain that controls movement and motivation.
Date
A new study aims to understand insulin resistance in people with Parkinson's, and how this could inform future drug trials of existing diabetes treatments.